Abide and ActivX Complete Technology Agreement:

SAN DIEGO and PRINCETON, N.J, Dec. 12, 2012 — We are pleased to announce that Abide Therapeutics, Inc., San Diego CA, has entered into an agreement with ActivX Biosciences, Inc., La Jolla, CA, a leader in the field of activity based proteomics, granting Abide access to ActivX’s proprietary serine hydrolase technologies. ActivX, in conjunction with The Scripps Research Institute has …

Abide Therapeutics and SCYNEXIS, Inc. Collaborate In Finding Novel Anti-Viral and Anti-Parasitic Agents

RESEARCH TRIANGLE PARK, N.C. – SCYNEXIS, Inc. announced today that it has signed an agreement with Abide Therapeutics to collaborate in the search for novel anti-viral and anti-parasitic therapeutic compounds for human and animal health applications. Under the agreement, SCYNEXIS will screen, through its diverse biological screening platforms, Abide’s proprietary serine hydrolaseprotease inhibitor library with the objective of identifying compounds …